169 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Not yet recruiting A Randomized Study Evaluating the Safety and Efficacy of Luliconazole Cream in Pediatric Subjects With Tinea Corporis
Condition: Tinea
Interventions: Drug: Luliconazole Cream 1%;   Drug: Vehicle Cream
22 Not yet recruiting Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
Condition: Herpes Labialis
Interventions: Drug: ZEP-3 ointment 1.0%;   Drug: Acyclovir cream 5%
23 Recruiting Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Condition: External Genital Warts
Interventions: Drug: LFX453;   Drug: Aldara®
24 Recruiting An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis
Condition: Tinea Corporis
Interventions: Drug: Naftin® Cream, 2% (younger pediatric cohort);   Drug: Naftin® Cream, 2% (older pediatric cohort)
25 Recruiting A Pilot Study - Safety and Efficacy of Nailprotex® for Onychomycosis Treatment
Conditions: Onychomycosis;   Chronic Paronychia
Intervention: Drug: Nailprotex
26 Recruiting Topical NVN1000 for the Treatment of External Genital and Perianal Warts
Conditions: Genital Warts;   Perianal Warts
Interventions: Drug: NVN1000;   Other: Vehicle Gel
27 Recruiting A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole;   Drug: Glucocorticoids
28 Recruiting Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis
Condition: Onychomycosis
Intervention: Device: CURE-EX device
29 Not yet recruiting Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
30 Recruiting Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa
Condition: Visceral Leishmaniasis
Intervention: Drug: Miltefosine
31 Not yet recruiting Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Intervention: Drug: Miltefosine
32 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition: Leishmaniasis
Intervention: Drug: Miltefosine
33 Not yet recruiting Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
Condition: Leishmaniasis or Other Uses of Miltefosine
Intervention: Drug: Miltefosine
34 Recruiting Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients
Condition: Hidradenitis Suppurativa (Acne Inversa)
Intervention: Biological: CJM112
35 Not yet recruiting Lyme Borreliosis and Early Cutaneous Diagnostic
Condition: Erythema Migrans
Intervention: Procedure: Skin biopsies
36 Not yet recruiting Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children
Condition: Scabies
Interventions: Drug: Ivermectin;   Drug: Permethrin
37 Recruiting Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
38 Not yet recruiting Single Ascending Oral Dose Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: F901318 safety;   Drug: F901318 tolerability;   Drug: F901318 pharmacokinetics;   Other: Placebo safety;   Other: Placebo tolerability;   Other: Placebo pharmacokinetics
39 Recruiting Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris
Conditions: Tinea Pedis;   Tinea Cruris
Intervention: Drug: Omeprazole 40mg
40 Recruiting Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Condition: Warts
Interventions: Biological: CANDIN;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years